CLINICAL_TRIALS trial_result · 2019-12-13

Clinical Trial Update: A Study of ENMD-2076 in Ovarian Clear Cell Cancers [Phase 2]

Phase 2 trial studying ENMD-2076 in ovarian clear cell carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University Health Network, Toronto | Conditions: Ovarian Clear Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-12-13